IFITM3 Restricts Influenza A Virus Entry by Blocking the Formation of Fusion Pores following Virus-Endosome Hemifusion

PLoS Pathogens

Volumn 10, Issue 4, 2014, Pages

  Desai, Tanay M ^a   Marin, Mariana ^a   Chin, Christopher R ^b   Savidis, George ^b   Brass, Abraham L ^b   Melikyan, Gregory B ^a,c  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; INTERFERON INDUCED TRANSMEMBRANE PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; IFITM3 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ARTICLE; CELL FUSION; CELLULAR DISTRIBUTION; CHANNEL GATING; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENDOSOME; GENE SILENCING; HUMAN; HUMAN CELL; IMAGING; INFLUENZA VIRUS A; NONHUMAN; PH; PROTEIN EXPRESSION; VIRUS CELL INTERACTION; VIRUS ENTRY; WESTERN BLOTTING; ANIMAL; CHO CELL LINE; CRICETULUS; GENETICS; HAMSTER; HEK293 CELL LINE; IMMUNOLOGY; INFLUENZA; MEMBRANE FUSION; METABOLISM;

ANIMALS; CHO CELLS; CHOLESTEROL; CRICETINAE; CRICETULUS; ENDOSOMES; HEK293 CELLS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MEMBRANE FUSION; MEMBRANE PROTEINS; RNA-BINDING PROTEINS; VIRUS INTERNALIZATION;

EID: 84901337841     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004048     Document Type: Article

References (58)

1. Diamond MS, Farzan M, (2013) The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 13: 46-57.
2. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254.
3. Perreira JM, Chin CR, Feeley EM, Brass AL, (2013) IFITMs Restrict the Replication of Multiple Pathogenic Viruses. J Mol Biol 425: 4937-55 doi:10.1016/j.jmb.2013.09.024.
4. Mudhasani R, Tran JP, Retterer C, Radoshitzky SR, Kota KP, et al. (2013) IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J Virol 87: 8451-8464.
5. Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, et al. (2013) IFITM proteins restrict viral membrane hemifusion. PLoS Pathog 9: e1003124.
6. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, et al. (2011) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 7: e1001258.
7. Jiang D, Weidner JM, Qing M, Pan XB, Guo H, et al. (2010) Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol 84: 8332-8341.
8. Bailey CC, Huang IC, Kam C, Farzan M, (2012) Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog 8: e1002909.
9. Everitt AR, Clare S, Pertel T, John SP, Wash RS, et al. (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484: 519-523.
10. Everitt AR, Clare S, McDonald JU, Kane L, Harcourt K, et al. (2013) Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model. PLoS ONE 8: e80723.
11. Chutiwitoonchai N, Hiyoshi M, Hiyoshi-Yoshidomi Y, Hashimoto M, Tokunaga K, et al. (2013) Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins. Microbes Infect 15: 280-290.
12. Lu J, Pan Q, Rong L, He W, Liu SL, et al. (2011) The IFITM proteins inhibit HIV-1 infection. J Virol 85: 2126-2137.
13. Feeley EM, Sims JS, John SP, Chin CR, Pertel T, et al. (2011) IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7: e1002337.
14. Amini-Bavil-Olyaee S, Choi YJ, Lee JH, Shi M, Huang IC, et al. (2013) The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 13: 452-464.
15. John SP, Chin CR, Perreira JM, Feeley EM, Aker AM, et al. (2013) The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication. J Virol 87: 7837-7852.
16. Yount JS, Moltedo B, Yang YY, Charron G, Moran TM, et al. (2010) Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat Chem Biol 6: 610-614.
17. Bailey CC, Kondur HR, Huang IC, Farzan M, (2013) Interferon-Induced Transmembrane Protein 3 is a Type II Transmembrane Protein. J Biol Chem 288doi:10.1074/jbc.M113.514356.
18. Sieczkarski SB, Whittaker GR, (2003) Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 4: 333-343.
19. Bolard J, (1986) Interaction of polyene antibiotics with membrane lipids: physicochemical studies of the molecular basis of selectivity. Drugs Exp Clin Res 12: 613-618.
20. Lin TY, Chin CR, Everitt AR, Clare S, Perreira JM, et al. (2013) Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction. Cell Rep 5: 895-908.
21. Rojek JM, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S, (2008) Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J Virol 82: 7677-7687.
22. Beer C, Andersen DS, Rojek A, Pedersen L, (2005) Caveola-dependent endocytic entry of amphotropic murine leukemia virus. J Virol 79: 10776-10787.
23. Cavrois M, De Noronha C, Greene WC, (2002) A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol 20: 1151-1154.
24. Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB, (2009) HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137: 433-444.
25. Tscherne DM, Manicassamy B, Garcia-Sastre A, (2010) An enzymatic virus-like particle assay for sensitive detection of virus entry. J Virol Methods 163: 336-343.
26. Chernomordik LV, Kozlov MM, (2005) Membrane hemifusion: crossing a chasm in two leaps. Cell 123: 375-382.
27. Cohen FS, Melikyan GB, (2004) The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement. J Membr Biol 199: 1-14.
28. Lakadamyali M, Rust MJ, Babcock HP, Zhuang X, (2003) Visualizing infection of individual influenza viruses. Proc Natl Acad Sci U S A 100: 9280-9285.
29. van der Schaar HM, Rust MJ, Waarts BL, van der Ende-Metselaar H, Kuhn RJ, et al. (2007) Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol 81: 12019-12028.
30. Melikyan GB, White JM, Cohen FS, (1995) GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes. J Cell Biol 131: 679-691.
31. Nour AM, Li Y, Wolenski J, Modis Y, (2013) Viral Membrane Fusion and Nucleocapsid Delivery into the Cytoplasm are Distinct Events in Some Flaviviruses. PLoS Pathog 9: e1003585.
32. Lowy RJ, Sarkar DP, Chen Y, Blumenthal R, (1990) Observation of single influenza virus-cell fusion and measurement by fluorescence video microscopy. Proc Natl Acad Sci U S A 87: 1850-1854.
33. Rubin RJ, Chen YD, (1990) Diffusion and redistribution of lipid-like molecules between membranes in virus-cell and cell-cell fusion systems. Biophys J 58: 1157-1167.
34. Tse FW, Iwata A, Almers W, (1993) Membrane flux through the pore formed by a fusogenic viral envelope protein during cell fusion. J Cell Biol 121: 543-552.
35. Chernomordik LV, Frolov VA, Leikina E, Bronk P, Zimmerberg J, (1998) The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation. J Cell Biol 140: 1369-1382.
36. Floyd DL, Ragains JR, Skehel JJ, Harrison SC, van Oijen AM, (2008) Single-particle kinetics of influenza virus membrane fusion. Proc Natl Acad Sci U S A 105: 15382-15387.
37. Padilla-Parra S, Marin M, Gahlaut N, Suter R, Kondo N, et al. (2013) Fusion of Mature HIV-1 Particles Leads to Complete Release of a Gag-GFP-Based Content Marker and Raises the Intraviral pH. PLoS ONE 8: e71002.
38. Koh CH, Cheung NS, (2006) Cellular mechanism of U18666A-mediated apoptosis in cultured murine cortical neurons: bridging Niemann-Pick disease type C and Alzheimer's disease. Cell Signal 18: 1844-1853.
39. Mukherjee S, Maxfield FR, (2004) Lipid and cholesterol trafficking in NPC. Biochim Biophys Acta 1685: 28-37.
40. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, et al. (2011) Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477: 340-343.
41. Cote M, Misasi J, Ren T, Bruchez A, Lee K, et al. (2011) Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477: 344-348.
42. Lafourcade C, Sobo K, Kieffer-Jaquinod S, Garin J, van der Goot FG, (2008) Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization. PLoS ONE 3: e2758.
43. Lenard J, Miller DK, (1981) pH-dependent hemolysis by influenza, Semliki, Forest virus, and Sendai virus. Virology 110: 479-482.
44. Wojtanik KM, Liscum L, (2003) The transport of low density lipoprotein-derived cholesterol to the plasma membrane is defective in NPC1 cells. J Biol Chem 278: 14850-14856.
45. Shoemaker CJ, Schornberg KL, Delos SE, Scully C, Pajouhesh H, et al. (2013) Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection. PLoS ONE 8: e56265.
46. Biswas S, Yin SR, Blank PS, Zimmerberg J, (2008) Cholesterol promotes hemifusion and pore widening in membrane fusion induced by influenza hemagglutinin. J Gen Physiol 131: 503-513.
47. Razinkov VI, Cohen FS, (2000) Sterols and sphingolipids strongly affect the growth of fusion pores induced by the hemagglutinin of influenza virus. Biochemistry 39: 13462-13468.
48. Domanska MK, Wrona D, Kasson PM, (2013) Multiphasic effects of cholesterol on influenza fusion kinetics reflect multiple mechanistic roles. Biophys J 105: 1383-1387.
49. Lev S, (2010) Non-vesicular lipid transport by lipid-transfer proteins and beyond. Nat Rev Mol Cell Biol 11: 739-750.
50. Le Blanc I, Luyet PP, Pons V, Ferguson C, Emans N, et al. (2005) Endosome-to-cytosol transport of viral nucleocapsids. Nat Cell Biol 7: 653-664.
51. Pasqual G, Rojek JM, Masin M, Chatton JY, Kunz S, (2011) Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog 7: e1002232.
52. Jha NK, Latinovic O, Martin E, Novitskiy G, Marin M, et al. (2011) Imaging single retrovirus entry through alternative receptor isoforms and intermediates of virus-endosome fusion. PLoS Pathog 7: e1001260.
53. Markosyan RM, Cohen FS, Melikyan GB, (2000) The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores. Mol Biol Cell 11: 1143-1152.
54. Zimmerberg J, Blumenthal R, Sarkar DP, Curran M, Morris SJ, (1994) Restricted movement of lipid and aqueous dyes through pores formed by influenza hemagglutinin during cell fusion. J Cell Biol 127: 1885-1894.
55. de la Vega M, Marin M, Kondo N, Miyauchi K, Kim Y, et al. (2011) Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion. Retrovirology 8: 99.
56. Cosset FL, Marianneau P, Verney G, Gallais F, Tordo N, et al. (2009) Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles. J Virol 83: 3228-3237.
57. Manicassamy B, Wang J, Jiang H, Rong L, (2005) Comprehensive analysis of ebola virus GP1 in viral entry. J Virol 79: 4793-4805.
58. Demirkhanyan LH, Marin M, Padilla-Parra S, Zhan C, Miyauchi K, et al. (2012) Multifaceted mechanisms of HIV-1 entry inhibition by human alpha-defensin. J Biol Chem 287: 28821-28838.